Literature DB >> 17852998

Critiques of the risk concept--valid or not?

Jørgen Nexøe1, Peder Andreas Halvorsen, Ivar Sønbø Kristiansen.   

Abstract

The increasing use of the risk concept in healthcare has caused concern among medical doctors, especially general practitioners (GPs). Critics have claimed that risk identification and intervention create unfounded anxiety, that the concept of risk is not useful at the individual patient level, that patients' risk concept is different from an epidemiological one, that resources are better spent elsewhere, or that commercial interests take advantage of risk information to promote sales. In this paper the authors discuss the concept of risk and address the critique. There is evidence that commercial interests promote risk interventions, that patients may misunderstand risk information, and that risk information can cause unnecessary anxiety. The authors have found no empirical data on the amount of time primary healthcare providers spend on risk interventions, and have not identified any valid arguments that risk information is not useful for the individual patient. Decision-making under uncertainty is a core element of medical practice, and GPs need to be suitably trained to inform patients such that they make good decisions when they are faced with uncertainty. The concept of risk is therefore useful for GPs, and in fact a key issue. It is concluded that risk critique should be based on sound theory and empirical data. Critics may do well in making clear distinctions between facts and value judgements.

Entities:  

Mesh:

Year:  2007        PMID: 17852998     DOI: 10.1080/14034940701418897

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  5 in total

1.  Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice.

Authors:  Charlotte Gry Harmsen; Ivar Sønbø Kristiansen; Pia Veldt Larsen; Jørgen Nexøe; Henrik Støvring; Dorte Gyrd-Hansen; Jesper Bo Nielsen; Adrian Edwards; Dorte Ejg Jarbøl
Journal:  Br J Gen Pract       Date:  2014-04       Impact factor: 5.386

Review 2.  Categorization and association analysis of risk factors for adverse drug events.

Authors:  Lina Zhou; Anamika Paul Rupa
Journal:  Eur J Clin Pharmacol       Date:  2017-12-08       Impact factor: 2.953

Review 3.  Positive predictive values of ≥5% in primary care for cancer: systematic review.

Authors:  Mark Shapley; Gemma Mansell; Joanne L Jordan; Kelvin P Jordan
Journal:  Br J Gen Pract       Date:  2010-09       Impact factor: 5.386

4.  The effect of disease onset chronology on mortality among patients with multimorbidity: A Danish nationwide register study.

Authors:  Tora G Willadsen; Volkert Siersma; Dagny R Nicolaisdóttir; Rasmus Køster-Rasmussen; Susanne Reventlow; Maarten Rozing
Journal:  J Multimorb Comorb       Date:  2022-08-21

Review 5.  The role of diseases, risk factors and symptoms in the definition of multimorbidity - a systematic review.

Authors:  Tora Grauers Willadsen; Anna Bebe; Rasmus Køster-Rasmussen; Dorte Ejg Jarbøl; Ann Dorrit Guassora; Frans Boch Waldorff; Susanne Reventlow; Niels de Fine Olivarius
Journal:  Scand J Prim Health Care       Date:  2016-03-08       Impact factor: 2.581

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.